Skip to main content
. 2018 Sep 20;68(11):1823–1830. doi: 10.1093/cid/ciy801

Figure 1.

Figure 1.

Isolates identified by minimum inhibitory concentration susceptibility status, platform, and gene targets. For ceftolozane/tazobactam the gene targets were blaNDM, -VIM, -IMP, and -KPC. For ceftazidime/avibactam the gene targets were blaNDM, -VIM, and -IMP. All gene targets were examined; only genes identified are presented. Abbreviations: BC-GN, gram-negative blood culture test; MIC, minimum inhibitory concentration.